Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine

被引：8
作者：
Pavithran, K [1 ]
Doval, DC [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res, New Delhi 110085, India
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2005年 / 28卷 / 02期
关键词：
papillary thyroid carcinoma; I-131; chronic myeloid leukemia; secondary CML;
D O I：
10.1097/01.coc.0000143845.79889.33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Leukemia as a second malignancy after treatment of thyroid cancer is rare. Most cases reported in the literature-have occurred after cumulative doses higher than 800 mCi and it is most commonly acute leukemias. We report a case of chronic myeloid leukemia (CML) occurring in a 40-year-old man 14 years after treatment of papillary thyroid carcinoma. Our patient had the longest interval between the diagnosis of CML and administration of I-131.
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [31] Cytologic Features of Mixed Papillary Carcinoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma of the Thyroid Gland
    Reid-Nicholson, Michelle
    Moreira, Andre
    Ramalingam, Preetha
    DIAGNOSTIC CYTOPATHOLOGY, 2008, 36 (11) : 813 - 817
  • [32] Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma
    Kim, Yonghan
    Roh, Jong-Lyel
    Song, Dongeun
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (05) : 906 - 913
  • [33] Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy
    Liu, Wen
    Jiang, Beibei
    Xue, Jingli
    Liu, Ruijing
    Wei, Yuqing
    Li, Peifeng
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 69
  • [34] Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation
    Lin, JD
    Chao, TC
    Huang, MJ
    Weng, HF
    Tzen, KY
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 77 - 81
  • [35] Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma
    Khan, Sameer
    Dunn, Joel
    Strickland, Nicola
    Al-Nahhas, Adil
    NUCLEAR MEDICINE REVIEW, 2008, 11 (01) : 30 - 33
  • [36] MISINTERPRETATION OF IODINE UPTAKE IN PAPILLARY THYROID-CARCINOMA AND PRIMARY LUNG ADENOCARCINOMA
    LANGSTEGER, W
    LIND, P
    KOLTRINGER, P
    BEHAM, A
    EBER, O
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (01) : 8 - 12
  • [37] Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib
    Oweini, Houssam
    Otrock, Zaher K.
    Mahfouz, Rami A. R.
    Bazarbachi, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (01) : 133 - 134
  • [38] Thyroglobulin-Based Risk Factor Repositioning for Determining Radioactive Iodine Activity in Patients with Papillary Thyroid Carcinoma: a Multicenter Retrospective Cohort Study
    Jeon, Subin
    Kwon, Seong Young
    Lee, Sang-Woo
    Bae, Sang Kyun
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (04) : 173 - 180
  • [39] Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib
    Houssam Oweini
    Zaher K. Otrock
    Rami A. R. Mahfouz
    Ali Bazarbachi
    Archives of Gynecology and Obstetrics, 2011, 283 : 133 - 134
  • [40] Thyroglobulin-Based Risk Factor Repositioning for Determining Radioactive Iodine Activity in Patients with Papillary Thyroid Carcinoma: a Multicenter Retrospective Cohort Study
    Subin Jeon
    Seong Young Kwon
    Sang-Woo Lee
    Sang Kyun Bae
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 173 - 180
12345